Acute Lymphoblastic Leukemia Philadelphia Chromosome-positive

• CLINICAL_TRIALS trial_result · 2021-06-29
  Clinical Trial Update: A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies [Phase 1, Phase 2]

  A Phase 1/2 study of oral AMN107 (imatinib) in adults with chronic myeloid leukemia and other hematologic malignancies has completed enrollm…

• CLINICAL_TRIALS trial_result · 2020-12-08
  Clinical Trial Update: A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL [Phase 1, Phase 2]

  Phase 1/2 trial update for AMN107 in adults with Glivec-intolerant chronic myeloid leukemia or relapsed/refractory Philadelphia chromosome–p…

• FDA approval · 2020-01-09
  FDA Approved: IMATINIB MESYLATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for imatinib mesylate from Teva Pharmaceuticals USA, Inc., under ANDA204285.

• CLINICAL_TRIALS trial_result · 2011-04-14
  Clinical Trial Update: BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia [Phase 1]

  A Phase 1 study of BMS-354825 (dasatinib) in patients with chronic myeloid leukemia in chronic, accelerated, or blast phases and Philadelphi…

• CLINICAL_TRIALS trial_result · 2011-04-14
  Clinical Trial Update: Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia [Phase 2]

  A Phase 2 clinical trial evaluated dasatinib in lymphoid blast phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lym…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.